Cargando…
Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC)...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334814/ https://www.ncbi.nlm.nih.gov/pubmed/35911705 http://dx.doi.org/10.3389/fimmu.2022.958360 |
_version_ | 1784759188727005184 |
---|---|
author | Liu, Zaoqu Kong, Ying Dang, Qin Weng, Siyuan Zheng, Youyang Ren, Yuqing Lv, Jinxiang Li, Na Han, Yilin Han, Xinwei |
author_facet | Liu, Zaoqu Kong, Ying Dang, Qin Weng, Siyuan Zheng, Youyang Ren, Yuqing Lv, Jinxiang Li, Na Han, Yilin Han, Xinwei |
author_sort | Liu, Zaoqu |
collection | PubMed |
description | Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC), and tumor microenvironment components, as critical components in PMN establishment, could be monitored by liquid biopsy. Intensive studies based on the molecular profile of liquid biopsy have made it a viable alternative to tissue biopsy. Meanwhile, the complex molecular mechanism and intercellular interaction are great challenges for applying liquid biopsy in clinical practice. This article reviews the cellular and molecular components involved in the establishment of the PMN and the promotion of metastasis, as well as the mechanisms of their interactions. Better knowledge of the characteristics of the PMN may facilitate the application of liquid biopsy for clinical diagnosis, prognosis, and treatment. |
format | Online Article Text |
id | pubmed-9334814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93348142022-07-30 Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application Liu, Zaoqu Kong, Ying Dang, Qin Weng, Siyuan Zheng, Youyang Ren, Yuqing Lv, Jinxiang Li, Na Han, Yilin Han, Xinwei Front Immunol Immunology Metastatic dissemination represents a hallmark of cancer that is responsible for the high mortality rate. Recently, emerging evidence demonstrates a time-series event—pre-metastatic niche (PMN) has a profound impact on cancer metastasis. Exosomes, cell-free DNA (cfDNA), circulating tumor cells (CTC), and tumor microenvironment components, as critical components in PMN establishment, could be monitored by liquid biopsy. Intensive studies based on the molecular profile of liquid biopsy have made it a viable alternative to tissue biopsy. Meanwhile, the complex molecular mechanism and intercellular interaction are great challenges for applying liquid biopsy in clinical practice. This article reviews the cellular and molecular components involved in the establishment of the PMN and the promotion of metastasis, as well as the mechanisms of their interactions. Better knowledge of the characteristics of the PMN may facilitate the application of liquid biopsy for clinical diagnosis, prognosis, and treatment. Frontiers Media S.A. 2022-07-15 /pmc/articles/PMC9334814/ /pubmed/35911705 http://dx.doi.org/10.3389/fimmu.2022.958360 Text en Copyright © 2022 Liu, Kong, Dang, Weng, Zheng, Ren, Lv, Li, Han and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Liu, Zaoqu Kong, Ying Dang, Qin Weng, Siyuan Zheng, Youyang Ren, Yuqing Lv, Jinxiang Li, Na Han, Yilin Han, Xinwei Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title | Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title_full | Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title_fullStr | Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title_full_unstemmed | Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title_short | Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application |
title_sort | liquid biopsy in pre-metastatic niche: from molecular mechanism to clinical application |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334814/ https://www.ncbi.nlm.nih.gov/pubmed/35911705 http://dx.doi.org/10.3389/fimmu.2022.958360 |
work_keys_str_mv | AT liuzaoqu liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT kongying liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT dangqin liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT wengsiyuan liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT zhengyouyang liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT renyuqing liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT lvjinxiang liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT lina liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT hanyilin liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication AT hanxinwei liquidbiopsyinpremetastaticnichefrommolecularmechanismtoclinicalapplication |